BioMarin Director Timothy Walbert Receives 7,490 Restricted Stock Units

BioMarin Pharmaceutical Inc. director Timothy P. Walbert received 7,490 restricted stock units on June 2, 2026, as reported in this Form 4 filing. The restricted stock units were granted at no cost (price not applicable) and represent an equity award to the director. Following this transaction, Walbert's direct holdings in BioMarin common stock increased to 17,270 shares. Additionally, he indirectly owns 416 shares through Prairie Capital Ventures LLC. The filing was signed by attorney-in-fact Tae Sang Yoo on June 4, 2026. This transaction represents standard equity compensation for board members and demonstrates ongoing alignment of director interests with shareholder value through stock ownership.